BAPTIST HEALTH MEDICAL CENTER - FS
1. Target Overview & Investment Thesis
BAPTIST HEALTH MEDICAL CENTER - FS is a 320-bed suburban community hospital in SEBASTIAN, AR with $279.1M in net patient revenue and a -13.1% operating margin. The hospital serves a payer mix of 30.7% Medicare, 8.6% Medicaid, and 60.8% commercial.
Thesis: Undervalued. Our ML models identify $20.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -13.1% to -5.8% (+736bps).
| Net Revenue HCRIS | $279.1M |
| Current EBITDA COMPUTED | $-36.7M |
| Operating Margin COMPUTED | -13.1% |
| Occupancy HCRIS | 51.9% |
| Revenue / Bed COMPUTED | $872K |
| Net-to-Gross HCRIS | 14.5% |
| Distress Probability ML | 48.4% |
2. Market Context & Competitive Position
AR has 108 Medicare-certified hospitals with a median operating margin of -7.6%. The target's margin of -13.1% places it below the state median. Among 17 size-comparable peers (160-640 beds), the median margin is 0.2%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (160-640), prioritizing same-state peers. 17 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| BAPTIST HEALTH MEDICAL CENTER (Target) | AR | 320 | $279.1M | -13.1% |
| UAMS MEDICAL CENTER | AR | 521 | $1.01B | -7.2% |
| ARKANSAS CHILDRENS HOSPITAL | AR | 326 | $759.4M | 7.9% |
| MERCY HOSPITAL FORT SMITH | AR | 256 | $447.1M | 13.8% |
| ST BERNARDS MEDICAL CENTER | AR | 384 | $425.3M | -18.1% |
| ST VINCENT INFIRMARY MEDICAL C | AR | 379 | $392.7M | -30.0% |
| MERCY MEDICAL CENTER | AR | 236 | $366.7M | 7.7% |
| WASHINGTON REGIONAL MEDICAL CE | AR | 377 | $352.8M | -2.2% |
| NORTHWEST MEDICAL CENTER | AR | 321 | $293.1M | 0.7% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $20.5M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $5.9M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $5.6M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $5.5M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $3.4M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $179K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-36.7M |
| + RCM Uplift | +$20.5M |
| Pro Forma EBITDA | $-16.1M |
| Current Margin | -13.1% |
| Pro Forma Margin | -5.8% |
| WC Released (1x) | $10.7M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-56.4M | $-36.6M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-56.4M | $-58.6M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-50.8M | $-9.1M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-50.8M | $-25.0M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-62.1M | $-121.0M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-62.1M | $-153.2M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 17 hospitals with 160-640 beds
- Same-state prioritization (n=18)
- Comp margins: P25=-11.9% / P50=0.2% / P75=6.6%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.